Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Artelo Biosciences, Inc. (ARTL) had Weighted-Average Shares Outstanding (Diluted) of 2.71M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.43M |
|
-- |
|
-- |
|
$2.50M |
|
$-2.50M |
|
$0.08M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.43M |
|
$-2.50M |
|
$-2.48M |
|
2.71M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.71M |
$-0.89 |
|
$-0.89 |
|
| Balance Sheet Financials | |
$4.37M |
|
-- |
|
$2.09M |
|
$6.46M |
|
$1.46M |
|
-- |
|
$0.01M |
|
$1.46M |
|
$5.00M |
|
$2.96M |
|
$5.00M |
|
4.19M |
|
| Cash Flow Statement Financials | |
$-6.22M |
|
-- |
|
$9.80M |
|
$0.60M |
|
$4.20M |
|
$3.60M |
|
$0.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-48.57% |
|
-82.05% |
|
-37.58% |
|
-48.57% |
|
$1.19 |
|
$-2.29 |
|
$-2.29 |
|